“…The second limitation of GENOA v1.0 is its inability to reduce mechanisms with multiple SOA precursors simultaneously, whereas some precursors may share common or similar chemical pathways. As presented in Wang et al (2022), only one initial SOA precursor (i.e., beta-caryophyllene) is considered in the sesquiterpene mechanism adopted in GENOA v1.0. The reduction was performed with a single initial concentration of sesquiterpene of 10 μg/m 3 for all conditions.…”